Profile data is unavailable for this security.
About the company
MIRA Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical development company. The Company has two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. It holds exclusive license rights in the United States, Canada and Mexico for Ketamir-2, a patent pending oral ketamine analog under pre-clinical investigation to potentially deliver ultra-rapid antidepressant effects, providing hope for individuals battling treatment-resistant depression (TRD), major depressive disorder with suicidal ideation (MDSI) and potentially post-traumatic stress disorder (PTSD). Its oral pharmaceutical marijuana molecule, MIRA-55, is being studied for its potential to alleviate neuropathic pain, as well as anxiety and cognitive decline, symptoms commonly associated with early-stage dementia.
- Revenue in USD (TTM)0.00
- Net income in USD-12.36m
- Incorporated2020
- Employees3.00
- LocationMira Pharmaceuticals Inc1200 Brickell Avenue, Suite 1950 #1183MIAMI 33131United StatesUSA
- Phone+1 (813) 369-5150
- Websitehttps://mirapharmaceuticals.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Galera Therapeutics Inc | 0.00 | -45.75m | 11.70m | 7.00 | -- | -- | -- | -- | -0.9971 | -0.9971 | 0.00 | -2.48 | 0.00 | -- | -- | 0.00 | -115.30 | -83.69 | -142.79 | -97.54 | -- | -- | -- | -- | -- | -6.49 | 9.23 | -- | -- | -- | 5.05 | -- | -29.84 | -- |
| Transcode Therapeutics Inc | 0.00 | -17.06m | 11.75m | 10.00 | -- | 2.25 | -- | -- | -206.36 | -206.36 | 0.00 | 0.7893 | 0.00 | -- | -- | 0.00 | -264.82 | -133.14 | -721.90 | -181.26 | -- | -- | -- | -- | -- | -148.05 | 0.00 | -- | -- | -- | -5.59 | -- | -- | -- |
| Enzolytics Inc | 0.00 | -119.19k | 11.80m | 2.00 | -- | -- | -- | -- | -0.106 | -0.106 | 0.00 | -1.04 | 0.00 | -- | -- | -- | -369.52 | -- | -- | -- | -- | -- | -- | -- | -- | -4.30 | -- | -- | -100.00 | -- | -9.35 | -- | -- | -- |
| Sunshine Biopharma Inc | 26.74m | -4.09m | 11.87m | 44.00 | -- | 0.0251 | -- | 0.4439 | -13.35 | -13.35 | 76.96 | 24.96 | 0.9081 | 3.13 | 11.58 | 607,722.50 | -13.88 | -101.52 | -17.99 | -137.04 | 33.15 | 35.47 | -15.29 | -165.33 | 3.23 | -- | 0.00 | -- | 454.42 | -- | 83.15 | -- | 110.99 | -- |
| Pioneer Green Farms Inc | 40.05k | -537.65k | 11.94m | 6.00 | -- | -- | -- | 298.10 | -0.0228 | -0.0228 | 0.0017 | -0.0243 | 0.0664 | 1.01 | -- | 6,675.00 | -89.14 | -- | -- | -- | 26.59 | -- | -1,342.45 | -- | 0.0099 | -155.92 | 14.08 | -- | -- | -- | 35.41 | -- | -- | -- |
| Avalo Therapeutics Inc | 1.45m | -142.88m | 12.08m | 19.00 | -- | -- | -- | 8.33 | -318.69 | -318.69 | 3.02 | -97.75 | 0.0181 | -- | 3.25 | 76,315.79 | -178.64 | -99.64 | -- | -154.42 | 54.90 | 84.69 | -9,853.73 | -613.58 | -- | -0.2415 | -- | -- | -89.34 | -22.83 | 24.28 | -- | -22.48 | -- |
| Mira Pharmaceuticals Inc | 0.00 | -12.36m | 12.09m | 3.00 | -- | 3.83 | -- | -- | -0.8276 | -0.8276 | 0.00 | 0.2136 | 0.00 | -- | -- | 0.00 | -587.64 | -- | -1,721.90 | -- | -- | -- | -- | -- | -- | -2.63 | 0.00 | -- | -- | -- | -69.77 | -- | -- | -- |
| Guardion Health Sciences Inc | 12.06m | -5.12m | 12.24m | 9.00 | -- | 3.58 | -- | 1.01 | -4.00 | -4.00 | 9.49 | 2.66 | 0.9718 | 2.63 | 5.96 | 1,340,280.00 | -41.26 | -77.90 | -47.92 | -86.55 | 43.43 | 42.45 | -42.46 | -176.93 | 6.49 | -4.24 | 0.00 | -- | 10.85 | 67.03 | 101.00 | -- | -58.56 | -- |
| Marizyme Inc | 645.81k | -65.35m | 12.26m | 11.00 | -- | -- | -- | 18.98 | -1.43 | -1.43 | 0.0142 | -0.0354 | 0.0213 | 1.56 | 8.72 | 58,710.00 | -215.30 | -59.02 | -351.53 | -64.47 | 70.87 | 70.38 | -10,118.60 | -9,435.92 | 0.0458 | -0.6565 | 1.36 | -- | 176.59 | 99.98 | -71.22 | -- | -- | -- |
| Lotus Pharmaceuticals Inc | 70.79m | 1.72m | 12.39m | 233.00 | 0.0831 | 0.0013 | 3.21 | 0.1751 | 0.0553 | 0.0553 | 2.56 | 3.58 | 0.6321 | 37.27 | 17.85 | 303,836.90 | 1.55 | 22.84 | 1.71 | 26.40 | 35.10 | 41.62 | 2.45 | 19.93 | 0.4428 | 30.80 | 0.0516 | 0.00 | 28.71 | 31.70 | -12.22 | 51.11 | 70.48 | -- |
| ELEVAI Labs Inc | 2.18m | -4.62m | 12.47m | 18.00 | -- | 4.60 | -- | 5.71 | -0.2665 | -0.2665 | 0.126 | 0.1435 | -- | -- | -- | 121,351.70 | -- | -- | -- | -- | 67.84 | -- | -211.42 | -- | 1.80 | -- | 0.00 | -- | 123.50 | -- | -138.94 | -- | -- | -- |
| Plus Therapeutics Inc (USA) | 6.08m | -11.77m | 12.61m | 20.00 | -- | -- | -- | 2.07 | -3.19 | -3.19 | 1.67 | -1.13 | 0.5724 | -- | -- | 304,200.00 | -110.75 | -59.18 | -- | -133.04 | -- | -- | -193.49 | -470.45 | -- | -- | -- | -- | 2,093.30 | -5.89 | 34.32 | -- | 3.77 | -- |
| GlucoTrack Inc | 0.00 | -8.74m | 12.71m | 6.00 | -- | 33.02 | -- | -- | -1.87 | -1.87 | 0.00 | 0.0703 | 0.00 | -- | -- | 0.00 | -520.58 | -94.01 | -2,110.63 | -142.35 | -- | -- | -- | -10,447.96 | -- | -- | 0.3415 | -- | -- | -- | -60.02 | -- | -- | -- |
Data as of May 31 2024. Currency figures normalised to Mira Pharmaceuticals Inc's reporting currency: US Dollar USD
4.17%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Cross Staff Investments, Inc.as of 31 Mar 2024 | 383.40k | 2.59% |
| Virtu Americas LLCas of 31 Mar 2024 | 63.06k | 0.43% |
| Suncoast Equity Management LLCas of 31 Mar 2024 | 40.00k | 0.27% |
| HRT Financial LLCas of 31 Mar 2024 | 30.65k | 0.21% |
| Praetorian Wealth Management, Inc.as of 31 Mar 2024 | 27.50k | 0.19% |
| XTX Markets LLCas of 31 Mar 2024 | 25.54k | 0.17% |
| G1 Execution Services LLCas of 31 Mar 2024 | 15.57k | 0.11% |
| Northern Trust Global Investments Ltd.as of 31 Mar 2024 | 10.23k | 0.07% |
| Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 2024 | 10.23k | 0.07% |
| Cary Street Partners Investment Advisory LLCas of 31 Mar 2024 | 10.00k | 0.07% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
